Our investigation demonstrated that lentivirus-mediated RNAi silencing targeting ABCC2 might reverse the ABCC2-related drug resistance of NPC cell line CNE2 against cisplatin. The gene discussed is ABCC2; the disease is nasopharyngeal carcinoma.